Results 101 to 110 of about 7,635 (213)

Retinoic acid increases the effect of bone morphogenetic protein type 2 on osteogenic differentiation of human adipose-derived stem cells

open access: yesJournal of Applied Oral Science, 2019
Bone morphogenetic protein type 2 (BMP-2) and retinoic acid (RA) are osteoinductive factors that stimulate endogenous mechanisms of bone repair which can be applied on management of osseous defects in oral and maxillofacial fields.
Ariadne Cristiane Cabral CRUZ   +3 more
doaj   +1 more source

Comparison In Vitro Study on the Interface between Skin and Bone Cell Cultures and Microporous Titanium Samples Manufactured with 3D Printing Technology Versus Sintered Samples

open access: yesNanomaterials
Percutaneous implants osseointegrated into the residuum of a person with limb amputation need to provide mechanical stability and protection against infections.
Maxim Shevtsov   +5 more
doaj   +1 more source

Specific immunohistochemical localization of osteonectin and collagen types I and III in fetal and adult porcine dental tissues.

open access: yes, 1985
Affinity-purified antibodies have been used in combination with the peroxidase-antiperoxidase technique to study the distribution of osteonectin and collagen types I and III in porcine dental tissues.
S Wasi, P S Tung, J Sodek, C Domenicucci
core   +1 more source

Inflammatory-Driven Angiogenesis in Bone Augmentation with Bovine Hydroxyapatite, B-Tricalcium Phosphate, and Bioglasses: A Comparative Study

open access: yesJournal of Immunology Research, 2018
Introduction. The clinical use of bioactive materials for bone augmentation has remained a challenge because of predictability and effectiveness concerns, as well as increased costs.
Vlad M. Anghelescu   +9 more
doaj   +1 more source

Immunohistochemical localization of osteonectin in developing human and calf bone using monoclonal antibodies.

open access: yes, 1988
Osteonectin was immunolocalized in human fetal and calf neonatal developing bone using newly developed monoclonal antibodies. The protein was localized to the cytoplasm of osteoblasts and young osteocytes.
BIANCO, Paolo   +3 more
core   +1 more source

Addition of bone morphogenetic protein type 2 to ascorbate and β-glycerophosphate supplementation did not enhance osteogenic differentiation of human adipose-derived stem cells

open access: yesJournal of Applied Oral Science, 2012
Bone morphogenetic protein type 2 (BMP-2) is a potent local factor, which promotes bone formation and has been used as an osteogenic supplement for mesenchymal stem cells.
Ariadne Cristiane Cabral Cruz   +3 more
doaj  

Adiponectin effects on osteonectin gene expression in vascular smooth muscle cell line [PDF]

open access: yes, 2014
Background and purpose: Atherosclerosis is a major cause of death in adults in most countries. Many studies have focused on the protective role and anti-inflammatory properties of adiponectin but its role in calcification has been less studied.
Gatreh Samani, Keihan.   +3 more
core  

Osteocalcin and osteonectin expression after double application of platelet-rich plasma in rabbits.

open access: yes, 2016
Platelet-rich plasma (PRP) is a novel method for transferring autogenous growth factors to the wound area. The aim of this study was to evaluate the efficacy of double-application of PRP (DA-PRP) on bone healing in rabbit cranial defects by examining ...
Ozdemir, Burcu   +4 more
core   +1 more source

Changes in the expression of Fas, osteonectin and osteocalcin with age in the rabbit growth plate

open access: yes, 1998
Chondrocytes of the growth plate are generally assumed to undergo apoptosis, but the mechanisms which induce this cell death are not known. The Fas receptor is a mediator of the apoptotic signal in some systems.
H. I. Roach   +3 more
core   +1 more source

Osteopontin but not osteonectin favors the metastatic growth of pancreatic cancer cell lines.

open access: yes, 2010
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related death in western countries and among the malignancies with the worst prognosis.
Zhivkova-Galunska, M;Adwan, H;Eyol, E;Kleeff, J;Kolb, A;Bergmann, F;Berger, MR
core  

Home - About - Disclaimer - Privacy